Abstract
AbstractAutomatic administration of drugs to control cardiovascular function during and after surgery has received considerable attention. Although the potential benefits associated with such a technology remain unquestioned, the several adaptive control strategies proposed thus far have had very limited success in practice. In developing robust adaptive control methodologies for drug dosing in cardiovascular applications, we have analysed a well-known multiple-model adaptive control strategy for blood pressure control. The results reveal that no guarantee of protection against actually inserting a destabilising controller into the closed-loop is given and one cannot even put a global upper bound on the time during which the destabilising controller is attached. We advocate caution towards issues which in the past may have been either disregarded or not subjected to a systematic analysis as instability could be fatal in the context of a clinical application.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.